ABBOTT LABORATORIES - 8-K Filing
Abbott Laboratories extends Change in Control Agreements for named executive officers through December 31, 2028. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $ABT
Read the full article at SEC EDGAR
Part of the story Natics Corp. - 8-K Filing (3 articles)